BE476705A - - Google Patents
Info
- Publication number
- BE476705A BE476705A BE476705DA BE476705A BE 476705 A BE476705 A BE 476705A BE 476705D A BE476705D A BE 476705DA BE 476705 A BE476705 A BE 476705A
- Authority
- BE
- Belgium
- Prior art keywords
- product
- free
- soluble
- active
- water
- Prior art date
Links
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 39
- 239000000047 product Substances 0.000 claims description 38
- 239000012141 concentrate Substances 0.000 claims description 28
- 239000000126 substance Substances 0.000 claims description 28
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 24
- 230000001076 estrogenic Effects 0.000 claims description 24
- 239000002904 solvent Substances 0.000 claims description 23
- 210000002700 Urine Anatomy 0.000 claims description 18
- 238000006460 hydrolysis reaction Methods 0.000 claims description 16
- JKKFKPJIXZFSSB-CBZIJGRNSA-N Estrone sulfate Chemical compound OS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 JKKFKPJIXZFSSB-CBZIJGRNSA-N 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 12
- 239000003960 organic solvent Substances 0.000 claims description 12
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Hiestrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 claims description 11
- 239000000262 estrogen Substances 0.000 claims description 11
- 239000002244 precipitate Substances 0.000 claims description 11
- 239000004480 active ingredient Substances 0.000 claims description 10
- 150000002576 ketones Chemical class 0.000 claims description 10
- 230000009245 menopause Effects 0.000 claims description 10
- 201000010874 syndrome Diseases 0.000 claims description 10
- 229960003399 Estrone Drugs 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- 241000700159 Rattus Species 0.000 claims description 8
- 230000001058 adult Effects 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 8
- 230000003780 keratinization Effects 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 231100000614 Poison Toxicity 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 229950008385 estrone sulphate Drugs 0.000 claims description 5
- 239000003440 toxic substance Substances 0.000 claims description 5
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 206010027304 Menopausal symptom Diseases 0.000 claims description 3
- 230000001476 alcoholic Effects 0.000 claims description 3
- 239000012223 aqueous fraction Substances 0.000 claims description 3
- 239000000727 fraction Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 2
- 238000004737 colorimetric analysis Methods 0.000 claims 2
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims 2
- 230000002485 urinary Effects 0.000 claims 2
- 229940011871 Estrogens Drugs 0.000 claims 1
- 239000005977 Ethylene Substances 0.000 claims 1
- 229940030484 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM ESTROGENS Drugs 0.000 claims 1
- 229940046080 endocrine therapy drugs Estrogens Drugs 0.000 claims 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 1
- 229910052938 sodium sulfate Inorganic materials 0.000 claims 1
- 235000011152 sodium sulphate Nutrition 0.000 claims 1
- 239000002195 soluble material Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 description 15
- 235000019441 ethanol Nutrition 0.000 description 14
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 14
- 229940106582 ESTROGENIC SUBSTANCES Drugs 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 10
- 239000003610 charcoal Substances 0.000 description 9
- -1 nitrogenous organic base Chemical class 0.000 description 9
- 238000001556 precipitation Methods 0.000 description 8
- 238000000605 extraction Methods 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 6
- 239000003463 adsorbent Substances 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 206010028813 Nausea Diseases 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Natural products OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000006011 modification reaction Methods 0.000 description 4
- 230000001264 neutralization Effects 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000001225 therapeutic Effects 0.000 description 4
- 229940088597 Hormone Drugs 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000002496 gastric Effects 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 150000002989 phenols Chemical class 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- XSJVWZAETSBXKU-UHFFFAOYSA-N 2-ethoxypropane Chemical compound CCOC(C)C XSJVWZAETSBXKU-UHFFFAOYSA-N 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N Carbon tetrachloride Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N Chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- HJOVHMDZYOCNQW-UHFFFAOYSA-N Isophorone Chemical compound CC1=CC(=O)CC(C)(C)C1 HJOVHMDZYOCNQW-UHFFFAOYSA-N 0.000 description 2
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000004432 carbon atoms Chemical group C* 0.000 description 2
- 230000005591 charge neutralization Effects 0.000 description 2
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 2
- OZXIZRZFGJZWBF-UHFFFAOYSA-N 1,3,5-trimethyl-2-(2,4,6-trimethylphenoxy)benzene Chemical compound CC1=CC(C)=CC(C)=C1OC1=C(C)C=C(C)C=C1C OZXIZRZFGJZWBF-UHFFFAOYSA-N 0.000 description 1
- PTTPXKJBFFKCEK-UHFFFAOYSA-N 2,6-dimethylheptan-4-one Chemical compound CC(C)CC(=O)CC(C)C PTTPXKJBFFKCEK-UHFFFAOYSA-N 0.000 description 1
- CATSNJVOTSVZJV-UHFFFAOYSA-N 2-Heptanone Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N Amyl acetate Chemical compound CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N Cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- SWXVUIWOUIDPGS-UHFFFAOYSA-N Diacetone alcohol Chemical compound CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N Ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- OJVAMHKKJGICOG-UHFFFAOYSA-N Hexane-2,5-dione Chemical compound CC(=O)CCC(C)=O OJVAMHKKJGICOG-UHFFFAOYSA-N 0.000 description 1
- 206010034759 Petit mal epilepsy Diseases 0.000 description 1
- 229960000747 Sodium estrone sulfate Drugs 0.000 description 1
- UGAPHEBNTGUMBB-UHFFFAOYSA-N acetic acid;ethyl acetate Chemical compound CC(O)=O.CCOC(C)=O UGAPHEBNTGUMBB-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- 230000003213 activating Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 230000002567 autonomic Effects 0.000 description 1
- 229910000394 calcium triphosphate Inorganic materials 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002996 emotional Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000002349 favourable Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 239000008079 hexane Substances 0.000 description 1
- 230000003054 hormonal Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- BXFFHSIDQOFMLE-UHFFFAOYSA-N indoxyl sulfate Chemical compound C1=CC=C2C(OS(=O)(=O)O)=CNC2=C1 BXFFHSIDQOFMLE-UHFFFAOYSA-N 0.000 description 1
- 230000000968 intestinal Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000005453 ketone based solvent Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- RFWLACFDYFIVMC-UHFFFAOYSA-D pentacalcium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O RFWLACFDYFIVMC-UHFFFAOYSA-D 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N triclene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 239000004552 water soluble powder Substances 0.000 description 1
Landscapes
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE476705A true BE476705A (de) |
Family
ID=124996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE476705D BE476705A (de) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE476705A (de) |
-
0
- BE BE476705D patent/BE476705A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0307626B1 (de) | Verfahren zur Herstellung eines gegen Oxidierung wirkenden Gewürzextraktes | |
| CA1041083A (fr) | Esters des 21-thiol-steroides_ | |
| EP2613792B1 (de) | Verfahren für die zubereitung eines raffinierten extrakts aus centella asiatica | |
| WO2001051596A2 (fr) | Procede d'extraction des insaponifiables des huiles vegetales au moyen de chloro-1-butane | |
| FR2510119A1 (fr) | Procede de separation de sterols ou de melanges de sterols | |
| EP3615036A1 (de) | 20-hydroxyekdysonextrakt in pharmazeutischer qualität, seine verwendung und seine herstellung | |
| FR2518406A1 (fr) | Nouveau procede d'obtention de substances vaso-actives extraites de feuilles de ginkgo | |
| BE1004239A3 (fr) | Purification de beta-acides en vue d'une hydrogenolyse et beta-acides ainsi purifies. | |
| BE476705A (de) | ||
| LU81684A1 (fr) | Procede d'elimination des sels de potassium des sous produits de distillation | |
| EP0012640B1 (de) | Verfahren zur Reinigung von Chenodesoxycholsäure und nach diesem Verfahren erhaltene Produkte | |
| FR2620702A1 (fr) | Procede de preparation d'irones naturelles | |
| CA1140155A (fr) | PROCEDE DE PREPARATION D'UN NOUVEAU DERIVE DU 1.alpha.,25-DIHYDROXY CHOLECALCIFEROL | |
| FR2519253A1 (fr) | Procede pour isoler des composes a effet laxatif du sene medicinal, ces composes et leurs utilisations therapeutiques | |
| EP0126691B1 (de) | Verfahren zur Herstellung eines therapeutisch anwendbaren Extraktes aus Brackenridgea zanguebarica, Extrakt und entsprechendes Medikament | |
| FR2725447A1 (fr) | Procede d'obtention d'oligomeres procyanidoliques | |
| WO2008061984A2 (fr) | Procede d'extraction d'aloine | |
| BE490718A (de) | ||
| FR2660656A1 (fr) | Procede pour l'isolement de l'indole et agent formant un complexe d'inclusion a utiliser dans ce procede. | |
| BE438280A (de) | ||
| CH320139A (fr) | Procédé pour isoler un cétostéroïde à partir d'un mélange le contenant | |
| FR2499554A1 (fr) | Procede pour la preparation de sclareol | |
| EP2125692A1 (de) | Verfahren zur anreicherung eines oleocanthalhaltigen extrakts | |
| BE528703A (de) | ||
| CH401088A (fr) | Procédé d'obtention du 1-rhamnoside de 6-méthyl-1,3,8-trihydroxyanthraquinone par extraction conditionnée de Rhamnacées |